// Arnold J. Levine 1 , Chris R. Harris 1 and Anna M. Puzio-Kuter 1 1 Cancer Institute of New Jersey, UMDNJ, New Brunswick, N.J. Correspondence: Arnold J. Levine, email: // Keywords : p53, parkinson disease, IGF-1, mTOR, RHEB Received : November 20, 2012, Accepted : November 27, 2012, Published : November 28, 2012
No takes yet. Share an insight, caveat, or question.
Levine et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: